Back to Search
Start Over
Pieris Pharmaceuticals and Seattle Genetics Announce Multi-Program Immuno-Oncology Collaboration
- Source :
- Plus Company Updates. February 14, 2018
- Publication Year :
- 2018
-
Abstract
- Germany: Pieris Pharmaceuticals, Inc. has issued the following press release: Pieris Pharmaceuticals, Inc. (NASDAQ: PIRS), a clinical-stage biotechnology company advancing novel biotherapeutics through its proprietary Anticalin(r) technology platform for cancer, [...]
Details
- Language :
- English
- Database :
- Gale General OneFile
- Journal :
- Plus Company Updates
- Publication Type :
- News
- Accession number :
- edsgcl.527500415